Login
← Go Back
Rubicon Research
RUBICON · Miscellaneous > Miscellaneous Listing date: Oct. 16, 2025
Stock Price vs Company Growth
1d
2.6%
1w
5.5%
1m
2.9%
3m
17.0%
all
18.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 744 2.6%
610
823
Company Overview
Sales
1,497 Cr
Growth: 27.1%
Profit after Tax
199 Cr
Growth: 23.8%
Mid Cap
12,257 Cr
P/E: 59.9x
Industry P/E: 29.4x
Fundamentals
Sales (Cr) ₹ 1,497
Growth 27.1%
EBITDA 22.3%
P/S 8.3x
Dividend 0.0%
P/E 59.9x
Book Value ₹ 1
PEG Ratio 2.2x
ROE 999.0%
P/B N/A
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
Rubicon Research, incorporated in 1999, is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. Further, the company has robust sales and distribution capabilities in the US.
Belongs to (2 Indices)